HMGCR and neoplasm: Proteolytic stability of HMGCR may also be negatively regulated by adenosine monophosphate-activated protein kinase (AMPK) [102], with its activity being closely correlated with tumor suppression when AMPK modulates mTOR and Akt pathways [104].